康华生物(300841)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300841 康华生物

已收盘 07-25 15:00:00

{"stockData":{"symbol":"300841","market":"SZ","secType":"STK","nameCN":"康华生物","latestPrice":68.8,"timestamp":1753427004000,"preClose":69.93,"halted":0,"volume":6755078,"delay":0,"changeRate":-0.0162,"floatShares":119000000,"shares":130000000,"eps":2.077,"marketStatus":"已收盘","change":-1.13,"latestTime":"07-25 15:00:00","open":69.92,"high":69.98,"low":68.3,"amount":467000000,"amplitude":0.024,"askPrice":68.82,"askSize":32,"bidPrice":68.8,"bidSize":440,"shortable":0,"etf":0,"ttmEps":2.077,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":69.93,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":76.92,"lowLimit":62.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":129946899,"isCdr":false,"pbRate":2.62,"roa":"--","peRate":33.124699,"roe":"0.6%","epsLYR":3.0279,"committee":0.140373,"marketValue":8940000000,"turnoverRate":0.0568,"status":1,"floatMarketCap":8182000000},"requestUrl":"/m/hq/s/300841","defaultTab":"news","newsList":[{"id":"2554768841","title":"7月25日康华生物现1786.5万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2554768841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554768841?lang=zh_cn&edition=full","pubTime":"2025-07-25 17:12","pubTimestamp":1753434752,"startTime":"0","endTime":"0","summary":"证券之星消息，7月25日康华生物发生大宗交易，交易数据如下：大宗交易成交价格67.42元，相对当日收盘价折价2.01%，成交26.5万股，成交金额1786.5万元，买方营业部为方正证券股份有限公司上海浦东新区成山路证券营业部，卖方营业部为东亚前海证券有限责任公司上海分公司。近三个月该股共发生9笔大宗交易，合计成交1.97万手，折价成交9笔。截至2025年7月25日收盘，康华生物报收于68.8元，下跌1.62%，换手率5.68%，成交量6.76万手，成交额4.67亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500027830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300841","BK0239"],"gpt_icon":0},{"id":"2553270891","title":"7月24日康华生物涨6.12%，华夏行业景气混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2553270891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553270891?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:29","pubTimestamp":1753345759,"startTime":"0","endTime":"0","summary":"证券之星消息，7月24日康华生物涨6.12%，收盘报69.93元，换手率9.76%，成交量11.61万手，成交额7.94亿元。重仓康华生物的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏行业景气混合。华夏行业景气混合目前规模为72.61亿元，最新净值3.5972，较上一交易日下跌0.07%，近一年上涨48.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400025034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","160314","300841"],"gpt_icon":0},{"id":"2553720279","title":"动物疫苗概念盘中拉升，康华生物涨6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553720279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553720279?lang=zh_cn&edition=full","pubTime":"2025-07-24 14:33","pubTimestamp":1753338824,"startTime":"0","endTime":"0","summary":"07月24日，动物疫苗概念盘中拉升，截至14点33分，动物疫苗概念整体指数上涨1.00%，报994.010点。从个股上来看，该概念的成分股中，康华生物涨6.56%，贤丰控股、申联生物、海利生物涨幅居前。从资金上来看，截止发稿，动物疫苗概念主力净流入为-9781.34万，其中温氏股份受到资金热捧，主力净流入3618.56万；拉长时间线来看，该板块近20日主力资金净流入-13.41亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072414334494b7aa4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072414334494b7aa4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603718","300841","688098","159646","BK0239"],"gpt_icon":0},{"id":"2553985302","title":"康华生物易主！温州鞋王退出！最近2年业绩下滑较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2553985302","media":"深蓝财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553985302?lang=zh_cn&edition=full","pubTime":"2025-07-21 19:16","pubTimestamp":1753096560,"startTime":"0","endTime":"0","summary":"因为康华生物实际控制人王振滔鞋业发家，被称为“温州鞋王”。康华生物2020年6月16日上市，上市次年公司录得净利润8.2948亿元。2022年下降为5.9807亿元，2023年下降至5.0922亿元。2024年只有3.9865亿元，同比下降21.71%。2025年一季度净利润2071万元，同比下降86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU1Njc1NjA2NA==&mid=2247590729&idx=3&sn=521f192e918891ae47aa664cb392096d&chksm=fa210e7e95e7e8de9b68c6935ea9bc506df404b5d86673cf9c22be776891f0fa8bc953f859ea&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2553142251","title":"7月21日康华生物跌6.87%，华夏创业板中盘200ETF发起式联接A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2553142251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553142251?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:34","pubTimestamp":1753086876,"startTime":"0","endTime":"0","summary":"证券之星消息，7月21日康华生物跌6.87%，收盘报67.06元，换手率14.87%，成交量17.69万手，成交额11.76亿元。重仓康华生物的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华夏基金的华夏创业板中盘200ETF发起式联接A。华夏创业板中盘200ETF发起式联接A目前规模为0.27亿元，最新净值1.3482，较上一交易日下跌0.16%，近一年上涨56.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100021604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160325","300841","BK0239"],"gpt_icon":0},{"id":"2553257444","title":"上海国资出手！300841，提前暴涨16%，今日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2553257444","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553257444?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:31","pubTimestamp":1753061460,"startTime":"0","endTime":"0","summary":"上实资本与鹭布卡分别持有上实医药50%股权，上实资本为上海市国资委持股100%的孙公司。此外，上海生物医药并购基金、上海医药集团分别持有万可欣生物80.209%、19.79%的合伙份额。因万可欣生物无实控人，康华生物实控人将由王振滔变更为无实控人，公司股票7月21日复牌。上海生物医药并购基金于3月26日正式成立，由上海国投先导生物医药私募投资基金、上海医药、东富龙、君实生物、鹭布卡等联合发起。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656291149&idx=2&sn=1849b5533c1ed25bc04947e1a331f60f&chksm=8a8b0d8be69f902ff0637ff6c0c71a4261025c5d408062febc27d7e979421552534c057e0772&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656291149&idx=2&sn=1849b5533c1ed25bc04947e1a331f60f&chksm=8a8b0d8be69f902ff0637ff6c0c71a4261025c5d408062febc27d7e979421552534c057e0772&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2552364446","title":"300841，筹划控制权变更！明起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2552364446","media":"e公司","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552364446?lang=zh_cn&edition=full","pubTime":"2025-07-20 19:47","pubTimestamp":1753012020,"startTime":"0","endTime":"0","summary":"　　康华生物（维权）7月20日晚间公告，公司控股股东、实控人王振滔及其一致行动人奥康集团、股东康悦齐明，拟合计向上海万可欣生物科技合伙企业转让所持公司股份2846.66万股，占剔除公司回购账户股份后总股本的21.91%，转让价格约每股65.03元，合计为18.51亿元。　　回溯原委，康华生物日前公告，公司于7月11日收到控股股东、实际控制人王振滔通知，其正在筹划公司控制权变更相关事宜，该事项可能导致公司控股股东、实际控制人发生变更。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-07-20/doc-infhcnsm4139639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300841","BK0239"],"gpt_icon":0},{"id":"2552443173","title":"康华生物最新公告：公司控制权拟变更为无实际控制人状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2552443173","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552443173?lang=zh_cn&edition=full","pubTime":"2025-07-20 15:41","pubTimestamp":1752997275,"startTime":"0","endTime":"0","summary":"康华生物公告称，公司收到控股股东、实际控制人王振滔及其一致行动人奥康集团、康悦齐明与万可欣生物签订的《股份转让协议》及《表决权委托协议》。万可欣生物拟受让合计2,846.6638万股公司股份，转让价格为每股65.0266元，股份转让价款合计为18.51亿元。本次股份转让完成及表决权委托后，万可欣生物拥有公司表决权的比例为29.9893%，公司控股股东将由王振滔变更为万可欣生物，实际控制人将由王振滔变更为无实际控制人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000002656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2551711874","title":"康华生物：主营人用疫苗研发生产销售，无家用医疗器械产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2551711874","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551711874?lang=zh_cn&edition=full","pubTime":"2025-07-16 08:54","pubTimestamp":1752627247,"startTime":"0","endTime":"0","summary":"金融界7月16日消息，有投资者在互动平台向康华生物提问：董秘您好，目前疫苗行业竞争激烈，请问公司在家用医疗器械方面有哪些产品？公司回答表示：尊敬的投资者您好，公司当前主营业务为人用疫苗的研发、生产与销售，已取得药品注册证书的疫苗产品有冻干人用狂犬病疫苗（人二倍体细胞）和ACYW135群脑膜炎球菌多糖疫苗，目前没有家用医疗器械方面产品。感谢您的关注！\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/16085451724159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300841","BK0239","BK1583","BK1574","09996","BK1100","BK1222","159883","09997","159646"],"gpt_icon":0},{"id":"2551697401","title":"王振滔欲脱手康华生物控制权，“温州鞋王” 跨界折戟商业帝国何去何从","url":"https://stock-news.laohu8.com/highlight/detail?id=2551697401","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551697401?lang=zh_cn&edition=full","pubTime":"2025-07-15 18:21","pubTimestamp":1752574875,"startTime":"0","endTime":"0","summary":"一旦康华生物易主，王振滔的商业帝国将何去何从？王振滔筹划转让康华生物控股权，被解读为是缓解资金压力之举。公开披露显示，从2015年开始，王振滔已多次质押持有的奥康国际和康华生物股权。截至今年7月3日，王振滔、奥康集团累计质押的康华生物股份，已经分别达到持股数量的89.2%、71.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715184909a44c34bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715184909a44c34bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0107","BK0223","BK0039","BK0028","300841","BK0077","BK0188","BK0239","BK0093","603001"],"gpt_icon":0},{"id":"2551941155","title":"温州“鞋王”王振滔欲退场！康华生物筹划易主，停牌前股价“异动”","url":"https://stock-news.laohu8.com/highlight/detail?id=2551941155","media":"北京商报官方账号","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551941155?lang=zh_cn&edition=full","pubTime":"2025-07-13 19:15","pubTimestamp":1752405308,"startTime":"0","endTime":"0","summary":"康华生物表示，上述事项的具体方案尚在筹划中，存在不确定性。王振滔欲离场背后，康华生物业绩承压明显，今年一季度，公司净利同比下滑逾八成。康华生物归属净利润已连续三年出现下滑。康华生物彼时表示，本次立案调查事项系针对王振滔个人，被立案调查的事项与公司无关，公司经营活动不受影响。截至一季度末，王振滔直接持有康华生物1400万股股份，担任公司董事长，2024年在康华生物领薪237.5万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713191718a447c921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713191718a447c921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603001","BK0188","BK0107","BK0070","BK0093","BK0239","BK0223","300841","BK0039","BK0077","BK0028"],"gpt_icon":0},{"id":"2551941583","title":"300841、301012！筹划控制权变更，停牌！","url":"https://stock-news.laohu8.com/highlight/detail?id=2551941583","media":"e公司","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551941583?lang=zh_cn&edition=full","pubTime":"2025-07-13 18:55","pubTimestamp":1752404100,"startTime":"0","endTime":"0","summary":"　　资本整合节奏正在提速，7月13日晚间，又有两家公司宣布可能将面临控制权变更，将于明日进入停牌。　　标的之一康华生物（维权）从属奥康集团董事长王振滔旗下，后者有着“温州鞋王”的美誉。另一家公司扬电科技当下总市值为38亿元。　　康华生物公告显示，公司于7月11日收到控股股东、实际控制人王振滔通知，其正在筹划公司控制权变更相关事宜，该事项可能导致公司控股股东、实际控制人发生变更。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-07-13/doc-inffiqvm7459004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301012","300841","BK0224"],"gpt_icon":0},{"id":"2551945660","title":"康华生物最新公告：筹划控制权变更事项 股票停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2551945660","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551945660?lang=zh_cn&edition=full","pubTime":"2025-07-13 15:39","pubTimestamp":1752392370,"startTime":"0","endTime":"0","summary":"康华生物(300841.SZ)公告称，公司控股股东、实际控制人王振滔正在筹划公司控制权变更相关事宜，可能导致公司控股股东、实际控制人发生变更。经申请，公司股票自2025年7月14日开市起停牌，预计停牌时间不超过2个交易日。目前各方尚未签署相关协议，具体方案存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300002224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300841","BK0239"],"gpt_icon":0},{"id":"2550933844","title":"7月11日康华生物现3424.06万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2550933844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550933844?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:58","pubTimestamp":1752224328,"startTime":"0","endTime":"0","summary":"证券之星消息，7月11日康华生物发生大宗交易，交易数据如下：近三个月该股共发生3笔大宗交易，合计成交7204.0手，折价成交3笔。该股近期无解禁股上市。截至2025年7月11日收盘，康华生物(300841)报收于72.01元，上涨16.2%，换手率12.94%，成交量15.77万手，成交额10.8亿元。该股近半年内有股东持股变动，合计净减持63.2万股，股东增减持明细如下表：该股最近90天内共有2家机构给出评级，买入评级2家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100027186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2550879326","title":"7月9日康华生物现1451.18万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2550879326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550879326?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:56","pubTimestamp":1752051404,"startTime":"0","endTime":"0","summary":"证券之星消息，7月9日康华生物发生大宗交易，交易数据如下：大宗交易成交价格61.7元，相对当日收盘价折价2%，成交23.52万股，成交金额1451.18万元，买方营业部为中信证券股份有限公司北京呼家楼证券营业部，卖方营业部为民生证券股份有限公司上海普陀区光新路证券营业部。近三个月该股共发生1笔大宗交易，合计成交2352.0手，折价成交1笔。截至2025年7月9日收盘，康华生物报收于62.96元，下跌1.89%，换手率4.34%，成交量5.3万手，成交额3.29亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900026946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2549525300","title":"康华生物股价上涨1.68% 终止三项疫苗研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525300","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525300?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:26","pubTimestamp":1751984803,"startTime":"0","endTime":"0","summary":"康华生物最新股价报64.17元，较前一交易日上涨1.68%。当日成交量为32341手，成交金额达2.07亿元。康华生物主营业务为人用疫苗的研发、生产和销售。7月8日，康华生物发布公告称，决定终止与成都信然博创生物科技有限公司关于肺结核mRNA疫苗的研发项目，同时终止狂犬mRNA疫苗及带状疱疹mRNA疫苗的后续研发合作。数据显示，康华生物当日主力资金净流出510.51万元。2025年一季度，公司实现营业收入1.38亿元，归母净利润2071万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08222651570423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300841","159646"],"gpt_icon":0},{"id":"2549754966","title":"康华生物最新公告：终止与信然博创合作研发肺结核mRNA疫苗项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2549754966","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549754966?lang=zh_cn&edition=full","pubTime":"2025-07-08 19:01","pubTimestamp":1751972510,"startTime":"0","endTime":"0","summary":"康华生物(300841.SZ)公告称，近日公司与信然博创签署《补充协议（二）》，终止肺结核mRNA疫苗研发项目，以及狂犬mRNA疫苗及带状疱疹mRNA疫苗项目的后续研发合作。公司已建立自主研发团队并完成合作研发成果转移，此次终止合作是综合考虑公司整体经营发展规划做出的决策，不会对公司正常生产经营产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800032462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300841","159646","BK0239"],"gpt_icon":0},{"id":"2548803109","title":"康华生物（300841）股东王振滔、奥康集团有限公司合计质押387万股，占总股本2.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548803109","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548803109?lang=zh_cn&edition=full","pubTime":"2025-07-03 18:22","pubTimestamp":1751538145,"startTime":"0","endTime":"0","summary":"证券之星消息，康华生物7月3日公开信息显示，股东王振滔、奥康集团有限公司向天津信托有限责任公司合计质押387.0万股，占总股本2.91%。质押详情见下表：截止本公告日，股东奥康集团有限公司已累计质押股份1172.5万股，占其持股总数的71.91%，股东王振滔已累计质押股份1249.25万股，占其持股总数的89.2%。康华生物主营业务：疫苗研发、生产及销售业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300031760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300841","BK0239"],"gpt_icon":0},{"id":"2548078720","title":"【康华生物：股东宁波圣道及其一致行动人计划减持不超过2.44%公司股份】康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548078720","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548078720?lang=zh_cn&edition=full","pubTime":"2025-07-01 21:59","pubTimestamp":1751378368,"startTime":"0","endTime":"0","summary":"康华生物(300841.SZ)公告称，股东宁波圣道及其一致行动人淄博泰格计划在公告披露之日起3个交易日后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过3,165,765股，即不超过剔除公司回购专用账户股份后总股本的2.4362%。减持原因为自身资金需求，减持股份来源为公司首次公开发行前已发行的股份及资本公积转增股本取得的股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/01215951424411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300841"],"gpt_icon":0},{"id":"2548705430","title":"康华生物（300841）股东王振滔、奥康集团有限公司合计质押390万股，占总股本2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548705430","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548705430?lang=zh_cn&edition=full","pubTime":"2025-07-01 18:19","pubTimestamp":1751365161,"startTime":"0","endTime":"0","summary":"证券之星消息，康华生物7月1日公开信息显示，股东王振滔、奥康集团有限公司向天津信托有限责任公司合计质押390.0万股，占总股本2.93%。质押详情见下表：截止本公告日，股东奥康集团有限公司已累计质押股份1125.0万股，占其持股总数的69.0%，股东王振滔已累计质押股份1246.75万股，占其持股总数的89.02%。康华生物主营业务：疫苗研发、生产及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100030601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300841","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753486532458,"stockEarnings":[{"period":"1week","weight":-0.0446},{"period":"1month","weight":0.0658},{"period":"3month","weight":0.3313},{"period":"6month","weight":0.3521},{"period":"1year","weight":0.3949},{"period":"ytd","weight":0.2859}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都康华生物制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21584人(较上一季度减少9.47%)","perCapita":"5510股","listingDate":"2020-06-16","address":"四川省成都市龙泉驿区经济技术开发区北京路182号","registeredCapital":"12994万元","survey":"　　成都康华生物制品股份有限公司的主营业务是冻干人用狂犬病疫苗（人二倍体细胞）和ACYW135群脑膜炎球菌多糖疫苗生产和销售及其他疫苗的研发。公司的主要产品是冻干人用狂犬病疫苗（人二倍体细胞）、ACYW135群脑膜炎球菌多糖疫苗。公司冻干人用狂犬病疫苗（人二倍体细胞）先后被授予“国家重点新产品”、“四川省战略性新兴产品”等荣誉称号。","listedPrice":70.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康华生物(300841)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康华生物(300841)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康华生物,300841,康华生物股票,康华生物股票老虎,康华生物股票老虎国际,康华生物行情,康华生物股票行情,康华生物股价,康华生物股市,康华生物股票价格,康华生物股票交易,康华生物股票购买,康华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康华生物(300841)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康华生物(300841)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}